Anixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from US FDA ...

Retrieved on: 2021-05-20 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

Anixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from US FDA .... View article details on hiswai:

Excerpt

Since the target is a hormone receptor, this technology is also known as CER-T (Chimeric Endocrine Receptor T-cell) therapy, a new type of CAR-T. Dr.

Article found on: www.prnewswire.com